PENWEST PHARMACEUTICALS CO.
Patent Applications and Registrations
Patent applications and USPTO patent grants for PENWEST PHARMACEUTICALS CO..The latest application filed is for "sustained release formulation of nalbuphine".
Company Profile
0.11.35
Trademarks
- PENWEST PHARMACEUTICALS CO. - Chadds Ford PA US
- Penwest Pharmaceuticals Co. - Danbury CT
- Penwest Pharmaceuticals Co. - Patterson NY
- Penwest Pharmaceuticals Co. - Wappingers NY
- Penwest Pharmaceuticals Company - Danbury CT
- Penwest Pharmaceuticals Co. - 39 Old Ridgebury Road, Suite 11 Danbury CT
- Penwest Pharmaceuticals Company - Patterson NY
- Penwest Pharmaceuticals Co. - 2981 Route 22 Patterson US
Trademarks
Patent Activity
| Patent | Date |
|---|---|
| Sustained Release Formulation Of Nalbuphine App 20140271852 - BAICHWAL; Anand R. ; et al. | 2014-09-18 |
| Sustained Release Matrix Systems For Highly Soluble Drugs App 20140242166 - Baichwal; Anand R. ; et al. | 2014-08-28 |
| Sustained release formulation of nalbuphine Grant 8,765,175 - Baichwal , et al. July 1, 2 | 2014-07-01 |
| Sustained Release Formulation Of Nalbuphine App 20130164350 - BAICHWAL; ANAND R. ; et al. | 2013-06-27 |
| Sustained release formulations of nalbuphine Grant 8,394,812 - Baichwal , et al. March 12, 2 | 2013-03-12 |
| Delayed release dosage forms Grant 8,389,008 - Baichwal , et al. March 5, 2 | 2013-03-05 |
| Methods Of Providing Anticoagulation Effects In Subjects App 20120101169 - HAWI; Amale | 2012-04-26 |
| Synthesis Of Alpha-tocopherolquinone Derivatives, And Methods Of Using The Same App 20110263720 - PAISLEY; Steven D. ; et al. | 2011-10-27 |
| Chronotherapeutic dosage forms App 20090169587 - Baichwal; Anand R. ; et al. | 2009-07-02 |
| Robust sustained release formulations App 20080085304 - Baichwal; Anand R. ; et al. | 2008-04-10 |
| Robust sustained release formulations of oxymorphone and methods of use thereof App 20080085303 - Baichwal; Anand R. ; et al. | 2008-04-10 |
| Robust sustained release formulations of oxymorphone App 20080085305 - Baichwal; Anand R. ; et al. | 2008-04-10 |
| Sustained release formulations of oxymorphone App 20080050431 - Baichwal; Anand R. ; et al. | 2008-02-28 |
| Sustained release formulations of oxymorphone Grant 7,276,250 - Baichwal , et al. October 2, 2 | 2007-10-02 |
| Sustained release matrix systems for highly soluble drugs App 20070218137 - Baichwal; Anand R. ; et al. | 2007-09-20 |
| Ethanol-resistant sustained release formulations App 20070212414 - Baichwal; Anand R. ; et al. | 2007-09-13 |
| Sustained release torsemide dosage forms App 20070196482 - Sanghvi; Pradeep ; et al. | 2007-08-23 |
| Opioid formulations having reduced potential for abuse App 20070140975 - Baichwal; Anand R. ; et al. | 2007-06-21 |
| Sustained release formulations of metformin Grant 7,214,387 - Sanghvi , et al. May 8, 2 | 2007-05-08 |
| Sustained release formulations of nalbuphine App 20070048376 - Baichwal; Anand R. ; et al. | 2007-03-01 |
| Controlled release insufflation carrier for medicaments Grant 7,172,766 - Baichwal , et al. February 6, 2 | 2007-02-06 |
| Controlled release venlafaxine formulations App 20060228413 - Ketsela; Sara ; et al. | 2006-10-12 |
| Controlled release O-desmethylvenlafaxine formulations App 20060193912 - Ketsela; Sara ; et al. | 2006-08-31 |
| Controlled release venlafaxine formulations App 20060193911 - Ketsela; Sara ; et al. | 2006-08-31 |
| Sustained release heterodisperse hydrogel systems for insoluble drugs App 20060105035 - Baichwal; Anand R. | 2006-05-18 |
| Developing a delivery system for multi-pharmaceutical active materials at various release rates App 20050238715 - Liu, Lirong ; et al. | 2005-10-27 |
| Sustained release torsemide dosage forms App 20050169991 - Sanghvi, Pradeep ; et al. | 2005-08-04 |
| Chronotherapeutic dosage forms App 20050118267 - Baichwal, Anand R. ; et al. | 2005-06-02 |
| Delayed release dosage forms App 20050112201 - Baichwal, Anand R. ; et al. | 2005-05-26 |
| Once-a-day controlled release sulfonylurea formulation Grant 6,875,793 - Bhagwat , et al. April 5, 2 | 2005-04-05 |
| Sustained release heterodisperse hydrogel systems- amorphous drugs App 20040241233 - Baichwal, Anand | 2004-12-02 |
| Sustained release heterodisperse hydrogel systems for insoluble drugs App 20040234598 - Baichwal, Anand R. | 2004-11-25 |
| Sustained release matrix systems for highly soluble drugs App 20040170684 - Baichwal, Anand R. ; et al. | 2004-09-02 |
| Sustained release matrix for high-dose insoluble drugs App 20040121012 - Baichwal, Anand R. | 2004-06-24 |
| Sustained release formulations of metformin App 20040109891 - Sanghvi, Pradeep P. ; et al. | 2004-06-10 |
| Sustained release heterodisperse hydrogel systems for insoluble drugs Grant 6,726,930 - Baichwal April 27, 2 | 2004-04-27 |
| Sustained release heterodisperse hydrogel systems-amorphous drugs Grant 6,709,677 - Baichwal March 23, 2 | 2004-03-23 |
| Sustained release matrix for high-dose insoluble drugs Grant 6,689,386 - Baichwal February 10, 2 | 2004-02-10 |
| Methods of making sustained release formulations of oxymorphone App 20030129234 - Baichwal, Anand R. ; et al. | 2003-07-10 |
| Sustained release formulations of oxymorphone App 20030129230 - Baichwal, Anand R. ; et al. | 2003-07-10 |
| Pharmaceutical excipient having improved compressibility App 20030099702 - Staniforth, John N. ; et al. | 2003-05-29 |
| Controlled release insufflation carrier for medicaments App 20020090345 - Baichwal, Anand ; et al. | 2002-07-11 |
| Controlled release insufflation carrier for medicaments Grant 6,387,394 - Baichwal , et al. May 14, 2 | 2002-05-14 |
Company Registrations
| NCAGE Code | 594H3 | PENWEST PHARMACEUTICALS CO. |
| CAGE Code | 594H3 | PENWEST PHARMACEUTICALS CO. |
| DUNS | 002536456 | PENWEST PHARMACEUTICALS CO. |
| SEC | 0001047188 | PENWEST PHARMACEUTICALS CO of WASHINGTON |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 